Search Medication Guidelines

Keywords:
Type:
Filter:
Title
2015 Treatment of Mood Disorders During Pregnancy
*New 2017-2018 Florida Best Practice Psychotherapeutic Medication Guidelines for Adults - Full Set of Guidelines
*New* 2017-2018 Principles of Practice
*New* 2017-2018 Treatment of Adult Bipolar Disorder
*New* 2017-2018 Treatment of Adult Major Depressive Disorder
*New* 2017-2018 Treatment of Adult Schizophrenia
*2018 - 2019 Florida Best Practice Psychotherapeutic Medication Guidelines for Children and Adolescents - Full Set of Guidelines
2018 - 2019 Principles of Practice Regarding the Use of Psychotropic Medication in Children and Adolescents 6 to 17 Years Old
2018 - 2019 Principles of Practice Regarding the Use of Psychotropic Medication in Children Under Age 6
2018 – 2019 ADHD Medication Guidelines for Children and Adolescents
2018 – 2019 Aggression Medication Guidelines for Children and Adolescents
2018 – 2019 Anxiety Medication Guidelines for Children and Adolescents
2018 – 2019 Bipolar Disorders Medication Guidelines for Children and Adolescents
2018 – 2019 Insomnia Disorder Medication Guidelines for Children and Adolescents
2018 – 2019 Major Depression Medication Guidelines for Children and Adolescents
2018 – 2019 Monitoring Side-Effects of Antipsychotic Medication in Children and Adolescents
2018 – 2019 Obsessive-Compulsive Disorder Medication Guidelines for Children and Adolescents
2018 – 2019 PTSD Medication Guidelines for Children and Adolescents
2018 – 2019 Recommendations on DMDD in Children and Adolescents
2018 – 2019 Schizophrenia Medication Guidelines for Children and Adolescents
2018 – 2019 Tic Disorders Medication Guidelines for Children and Adolescents
*2018 – 2019 Antipsychotic High Dosing Table for Children and Adolescents
****NEW 2019 Autism Spectrum Disorder & Intellectual Developmental Disorder: Florida Best Practice Psychotherapeutic Medication Recommendations for Target Symptoms - Full Set of Guidelines
***NEW 2019 Principles of Practice in the Context of ASD & ID
***NEW 2019 Special Considerations in Children under Age 6 with ASD & ID
**NEW 2019 Use of Psychotherapeutic Medications and Routine Monitoring in the Context of ASD & ID
**NEW 2019 Adverse Effect Management During Atypical Antipsychotic Treatment in Youths with ASD & ID
**NEW 2019 Medication Optimization and Deprescribing in Children and Adolescents with ASD & ID
**NEW 2019 Complementary and Alternative Treatments for Children with ASD
**NEW 2019 Treatment of Hyperactive, Impulsive, and Inattentive Symptoms in the Context of ASD & ID
**NEW 2019 Treatment of Anxiety in the Context of ASD & ID
**NEW 2019 Treatment of Aggression in the Context of ASD & ID
**NEW 2019 Treatment of Sleep Disturbances in the Context of ASD & ID
**NEW 2019 Treatment of Restricted, Repetitive Behaviors in the Context of ASD & ID
**NEW 2019 Treatment of Depression or Bipolar Disorder in the Context of ASD & ID
**NEW 2019 Treatment of Catatonia in the Context of ASD & ID
**NEW 2019 Treatment of Psychosis in the Context of ASD & ID
For the highest-quality video, please view videos in the latest browser available. If you have any questions or issues, please contact Sabrina Singh.